[1] IPA. Data Reliability Guideline[S/OL]. (2017-02-10)[2017-09-01].http://www.ipapharma.org/news/ data-reliability-guideline.
[2] PIC/S. Good Practices For Data Management And Integrity In Regulated GMP/GDP Environments[S/OL]. (2015-05-26)[2017-09-01].https://picscheme.org/en/publications?tri=draft.
[3] MHRA. GxP Data Integrity Definitions and Guidance for Industry[S/OL]. (2016-07-21)[2017-09-01]. https://www.gov.uk/government/news/mhra-gxp-data-integrity-definitions-and-guidance-for-industry
[4] PDA. Points to Consider Elements of a Code of Conduct for Data Integrity[S/OL]. (2016-07-19)[2017-09-01].http://www.pda.org/scientific-and-regulatory-affairs/regulatory-resources/data-integrity.
[5] 郑平. 在药品生产质量关体系中的数据完整性[D].上海交通大学硕士学位论文, 2015:1.
[6] 李泮海,李进启,范秋英,等. 药品生产企业质量管理理念发展探讨[J]. 中国药物警戒,2011,8(2):93.
[7] CFDA.GMP附录:计算机系统[S/OL]. (2015-05-26)[2017-09-01]. http://www.sda.gov.cn/WS01/CL0087/120500.html.
[8] CFDA.药品数据管理规范(征求意见稿)[S/OL]. (2017-08-25)[2017-09-01]. http://www.sda.gov.cn/WS01/
CL0778/176732.html.
[9] WHO. Guidance on good data and record management practices[S/OL]. (2016-05-01)[2017-09-01].http://www.who.int/medicines/publications/pharmprep/WHO_TRS_996_annex05.pdf?ua=1.
[10] 国家食品药品监督管理总局食品药品审核查验中心.2016年度药品检查报告[S/OL]. (2017-06-02)[2017-09-01].http://www.cfdi.org.cn/resource/news/2016pdf_ch.html.